Daiwa Securities Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-262
| Closed | – | – | 1291 |
|
|
2024
Q3 | $0 | Hold |
262
| – | – | ﹤0.01% | 1287 |
|
|
2024
Q2 | $0 | Hold |
262
| – | – | ﹤0.01% | 1319 |
|
|
2024
Q1 | $1K | Hold |
262
| – | – | ﹤0.01% | 1284 |
|
|
2023
Q4 | $1K | Hold |
262
| – | – | ﹤0.01% | 1283 |
|
|
2023
Q3 | $1K | Hold |
262
| – | – | ﹤0.01% | 1235 |
|
|
2023
Q2 | $1K | Hold |
262
| – | – | ﹤0.01% | 1254 |
|
|
2023
Q1 | $2K | Hold |
262
| – | – | ﹤0.01% | 1199 |
|
|
2022
Q4 | $2K | Hold |
262
| – | – | ﹤0.01% | 1208 |
|
|
2022
Q3 | $3K | Hold |
262
| – | – | ﹤0.01% | 1182 |
|
|
2022
Q2 | $2K | Hold |
262
| – | – | ﹤0.01% | 1216 |
|
|
2022
Q1 | $3K | Hold |
262
| – | – | ﹤0.01% | 1207 |
|
|
2021
Q4 | $4K | Hold |
262
| – | – | ﹤0.01% | 1208 |
|
|
2021
Q3 | $4K | Buy |
262
+127
| +94% | +$1.94K | ﹤0.01% | 1186 |
|
|
2021
Q2 | $2K | Hold |
135
| – | – | ﹤0.01% | 1131 |
|
|
2021
Q1 | $2K | Hold |
135
| – | – | ﹤0.01% | 1137 |
|
|
2020
Q4 | $2K | Sell |
135
-261
| -66% | -$3.87K | ﹤0.01% | 1114 |
|
|
2020
Q3 | $7K | Hold |
396
| – | – | ﹤0.01% | 1055 |
|
|
2020
Q2 | $6K | Hold |
396
| – | – | ﹤0.01% | 1080 |
|
|
2020
Q1 | $6K | Hold |
396
| – | – | ﹤0.01% | 1078 |
|
|
2019
Q4 | $7K | Sell |
396
-44
| -10% | -$778 | ﹤0.01% | 1075 |
|
|
2019
Q3 | $9K | Hold |
440
| – | – | ﹤0.01% | 1025 |
|
|
2019
Q2 | $10K | Hold |
440
| – | – | ﹤0.01% | 1040 |
|
|
2019
Q1 | $6K | Buy |
440
+120
| +38% | +$1.64K | ﹤0.01% | 1054 |
|
|
2018
Q4 | $3K | Hold |
320
| – | – | ﹤0.01% | 1075 |
|
|
2018
Q3 | $5K | Hold |
320
| – | – | ﹤0.01% | 1066 |
|
|
2018
Q2 | $4K | Hold |
320
| – | – | ﹤0.01% | 1094 |
|
|
2018
Q1 | $4K | Buy |
+320
| New | +$4K | ﹤0.01% | 1077 |
|